JP2002138015A - Spray composition - Google Patents
Spray compositionInfo
- Publication number
- JP2002138015A JP2002138015A JP2000328836A JP2000328836A JP2002138015A JP 2002138015 A JP2002138015 A JP 2002138015A JP 2000328836 A JP2000328836 A JP 2000328836A JP 2000328836 A JP2000328836 A JP 2000328836A JP 2002138015 A JP2002138015 A JP 2002138015A
- Authority
- JP
- Japan
- Prior art keywords
- spray
- mass
- spray composition
- fat
- petroleum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007921 spray Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 239000002904 solvent Substances 0.000 claims abstract description 23
- 239000003208 petroleum Substances 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 8
- 230000008018 melting Effects 0.000 claims abstract description 7
- 238000002844 melting Methods 0.000 claims abstract description 7
- 239000003380 propellant Substances 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- -1 glycerin fatty acid ester Chemical class 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical group 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000005507 spraying Methods 0.000 abstract description 7
- 239000003925 fat Substances 0.000 description 31
- 235000019197 fats Nutrition 0.000 description 31
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 239000011550 stock solution Substances 0.000 description 20
- 239000002245 particle Substances 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003595 mist Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000003915 liquefied petroleum gas Substances 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- DINAZWYMBSZRQF-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate propane-1,2-diol Chemical compound CC(O)CO.CC(O)CO.CC(O)CO.CC(O)CO.CC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO DINAZWYMBSZRQF-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 description 1
- 229960000962 bufexamac Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は、人体用として好適
に用いられるスプレー組成物に関する。The present invention relates to a spray composition suitably used for a human body.
【０００２】[0002]
【従来の技術】噴霧吐出口を有する容器内に充填された
スプレー組成物は、当該噴霧吐出口を介して霧状に吐出
されるものであり、これらのスプレー組成物の或る種の
ものは人体用として用いられる。2. Description of the Related Art A spray composition filled in a container having a spray discharge port is discharged in the form of a mist through the spray discharge port. Used for human body.
【０００３】人体用として用いられるスプレー組成物に
おいては、例えば炎症が起きている個所、かゆみが生じ
ている個所などの目的部位に対し、噴霧させることによ
ってその内容物を塗布するが、実際に目的部位に付着す
る吐出物の量を制御することが困難である。[0003] In a spray composition used for the human body, the contents are applied by spraying to a target site such as a site where inflammation has occurred or a site where itching has occurred. It is difficult to control the amount of the ejected matter adhering to the site.
【０００４】すなわち、従来、スプレー組成物において
は、霧状に吐出される吐出物を構成する噴霧粒子は、そ
の粒子径が小さいものであるために大気中に噴霧された
ときに飛散し易く、また、適用対象面に対する付着性が
低いことから、噴霧された内容物が高い効率で付着され
ない、という問題がある。[0004] That is, conventionally, in a spray composition, the spray particles constituting the discharge in the form of a mist are easily dispersed when sprayed into the atmosphere because of their small particle size. Further, there is a problem that the sprayed contents are not adhered with high efficiency because the adherence to the surface to be applied is low.
【０００５】[0005]
【発明が解決しようとする課題】本発明は、以上のよう
な事情に基づいてなされたものであって、その目的は、
噴霧された内容物が高い効率で付着されるスプレー組成
物を提供することにある。DISCLOSURE OF THE INVENTION The present invention has been made based on the above circumstances, and its object is to provide:
It is an object of the present invention to provide a spray composition to which sprayed contents can be attached with high efficiency.
【０００６】[0006]
【課題を解決するための手段】本発明のスプレー組成物
は、原液６０〜８０質量％と、噴射剤２０〜４０質量％
とよりなり、原液が、融点が３０〜４０℃である油脂成
分６０〜９０質量％と、当該油脂成分を溶解する石油系
溶剤１０〜４０質量％とを含有することを特徴とする。The spray composition of the present invention comprises 60 to 80% by mass of a stock solution and 20 to 40% by mass of a propellant.
Wherein the stock solution contains 60 to 90% by mass of a fat or oil component having a melting point of 30 to 40 ° C, and 10 to 40% by mass of a petroleum-based solvent that dissolves the fat or oil component.
【０００７】本発明のスプレー組成物においては、噴霧
吐出口を有する容器内に充填され、当該噴霧吐出口を介
して吐出された吐出物において、原液中の油脂成分が析
出することを特徴とする。[0007] The spray composition of the present invention is characterized in that a fat component in a stock solution is deposited in a discharged material filled in a container having a spray discharge port and discharged through the spray discharge port. .
【０００８】本発明のスプレー組成物は、人体用として
用いられ、吐出されることによって析出した油脂成分
が、皮膚上において溶解するものであることが好まし
い。[0008] The spray composition of the present invention is used for the human body, and it is preferable that the fat component precipitated by being discharged dissolves on the skin.
【０００９】本発明のスプレー組成物においては、油脂
成分がグリセリン脂肪酸エステルよりなり、石油系溶剤
が炭素数１０〜１８の炭化水素系溶剤であることが好ま
しい。In the spray composition of the present invention, the oil component is preferably a glycerin fatty acid ester, and the petroleum solvent is preferably a hydrocarbon solvent having 10 to 18 carbon atoms.
【００１０】[0010]
【作用】以上のようなスプレー組成物によれば、原液
が、特定の油脂成分と当該油脂成分を溶解させる石油系
溶剤とを特定の割合で含有してなり、噴霧により霧状に
吐出される吐出物を構成する噴霧粒子において油脂成分
が析出するため、当該噴霧粒子が粘着性を帯びることに
より大径の粒子となり、飛散が抑制されると共に、当該
噴霧粒子の付着性が大きいものとなることから、適用対
象面に対して高い付着率で付着するようになり、従っ
て、噴霧された内容物が高い効率で付着されることとな
る。According to the spray composition as described above, the stock solution contains a specific fat component and a petroleum-based solvent that dissolves the fat component in a specific ratio, and is discharged in the form of a mist by spraying. Since the fat component is precipitated in the spray particles constituting the ejected material, the spray particles become sticky and become large-diameter particles, so that scattering is suppressed and the adhesion of the spray particles becomes large. As a result, the liquid adheres to the surface to be applied at a high adhesion rate, and therefore, the sprayed contents are adhered with high efficiency.
【００１１】[0011]
【発明の実施の形態】以下、本発明について詳細に説明
する。本発明のスプレー組成物は、原液と噴射剤とより
なり、噴霧吐出口を形成する噴射バルブ装置を備えた耐
圧容器よりなるスプレー容器内に充填されてスプレー製
品とされる。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail. The spray composition of the present invention is composed of a stock solution and a propellant, and is filled into a spray container comprising a pressure-resistant container provided with an injection valve device forming a spray discharge port to form a spray product.
【００１２】原液は、油脂成分と、当該油脂成分を溶解
する石油系溶剤とを必須成分として含有する。この原液
を構成する成分および溶剤の種類およびその各々の原液
全体に対する含有割合は、以下のとおりである。The stock solution contains, as essential components, a fat and oil component and a petroleum solvent that dissolves the fat and oil component. The types of components and solvents constituting this stock solution and the content ratio of each to the whole stock solution are as follows.
【００１３】油脂成分としては、融点が３０〜４０℃で
ある、例えば天然油脂、炭素数１２〜１８の脂肪酸基を
有するグリセリン脂肪酸エステルなどが用いられる。こ
の油脂成分は、その融点が３０〜４０℃のものであるこ
とにより、スプレー組成物が、例えば人体用として用い
られて皮膚上に吐出された場合には、吐出されることに
よって析出した油脂成分が体温によって溶解されること
となる。As the oil component, for example, natural oils and fats having a melting point of 30 to 40 ° C., and glycerin fatty acid esters having a fatty acid group having 12 to 18 carbon atoms are used. This fat component has a melting point of 30 to 40 ° C., so that when the spray composition is used, for example, for the human body and is discharged onto the skin, the fat component precipitated by being discharged Will be dissolved by body temperature.
【００１４】油脂成分の具体例としては、ココナツオイ
ル、パーム油、カカオ脂、硬化ひまし油、グリセリルモ
ノミリステート、グリセリルモノステアレート、デカグ
リセリルペンタステアレート、炭素数１２〜１８の飽和
脂肪酸のモノグリセリド、ジグリセリドおよびトリグリ
セリドの混合物、牛脂脂肪酸トリグリセライド、パラフ
ィンワックス、ヤシ油脂肪酸、パルミチン酸、牛脂脂肪
酸などが挙げられ、これらは単独で若しくは２種以上を
組み合わせて用いることができる。ここで、炭素数１２
〜１８の飽和脂肪酸のモノグリセリド、ジグリセリドお
よびトリグリセリドの混合物としては、例えば市販され
ている「ウイテプゾールＷ−３５」（Ｄｙｎａｍｉｔ
Ｎｏｂｅｌ社製）などが挙げられる。Specific examples of fats and oils include coconut oil, palm oil, cocoa butter, hydrogenated castor oil, glyceryl monomyristate, glyceryl monostearate, decaglyceryl pentastearate, monoglycerides of saturated fatty acids having 12 to 18 carbon atoms, Examples thereof include a mixture of diglyceride and triglyceride, tallow fatty acid triglyceride, paraffin wax, coconut oil fatty acid, palmitic acid, and tallow fatty acid, and these can be used alone or in combination of two or more. Here, carbon number 12
As a mixture of monoglycerides, diglycerides and triglycerides of saturated fatty acids of No. -18 to No. 18, for example, commercially available "Witepsol W-35" (Dynamit
Nobel).
【００１５】この油脂成分の含有割合は、原液全体に対
して６０〜９０質量％、好ましくは６０〜８０質量％と
される。油脂成分の含有割合が過小な場合には、組成物
が適用対象面に対して高い付着率を得ることができない
ものとなり、一方、油脂成分が過大な場合には、容器内
において油脂成分が常に溶解した状態とならなくなる。[0015] The content of the fat component is 60 to 90% by mass, preferably 60 to 80% by mass, based on the whole stock solution. If the content of the fat component is too small, the composition cannot obtain a high adhesion rate to the surface to be applied, while if the fat component is too large, the fat component is always contained in the container. It will not be in a dissolved state.
【００１６】上記の油脂成分を溶解する石油系溶剤とし
ては、例えば炭素数が１０〜１８、好ましくは炭素数が
１４〜１８の非親水性の炭化水素系溶剤が用いられる。
すなわち、例えばアルコールなどが用いられることはな
い。この石油系溶剤は、５℃以下の環境下においても油
脂成分を溶解した状態とすることができるものであるこ
とが好ましい。As the petroleum-based solvent for dissolving the oil component, for example, a non-hydrophilic hydrocarbon-based solvent having 10 to 18 carbon atoms, preferably 14 to 18 carbon atoms is used.
That is, for example, alcohol is not used. It is preferable that the petroleum-based solvent is capable of dissolving the fat component even under an environment of 5 ° C. or less.
【００１７】石油系溶剤の具体例としては、流動パラフ
ィン、ミネラルスピリッツ、オリーブ油、ホホバ油、イ
ソオクタン酸セチルなどが挙げられ、これらは単独で若
しくは２種以上を組み合わせて用いることができる。Specific examples of petroleum solvents include liquid paraffin, mineral spirits, olive oil, jojoba oil, cetyl isooctanoate, and the like, and these can be used alone or in combination of two or more.
【００１８】この石油系溶剤の含有割合は、原液全体に
対して１０〜４０質量％、好ましくは２０〜４０質量％
とされる。石油系溶剤の含有割合が過小な場合には、容
器内において油脂成分が常に溶解した状態とならず、一
方、石油系溶剤の含有割合が過大な場合には、組成物が
適用対象面に対して高い付着率を得ることができないも
のとなる。The content of the petroleum solvent is 10 to 40% by mass, preferably 20 to 40% by mass based on the whole stock solution.
It is said. If the content of the petroleum solvent is too small, the oil and fat component will not always be in a dissolved state in the container, while if the content of the petroleum solvent is too large, the composition will Therefore, a high adhesion rate cannot be obtained.
【００１９】本発明のスプレー組成物を構成する原液中
には、非水系の種々の成分が含有されていてもよい。そ
してその具体例としては、例えば、有効成分、粉末、香
料、着色料、その他を挙げることができる。The stock solution constituting the spray composition of the present invention may contain various non-aqueous components. Specific examples thereof include, for example, an active ingredient, a powder, a fragrance, a coloring agent, and the like.
【００２０】有効成分の具体例としては、例えばインド
メタシン、Ｌ−メントール、ブフェキサマック、酸化亜
鉛、リドカイン、グリチルレチン酸、塩酸ジブカイン、
紫外線吸収剤などが挙げられ、これらは単独で若しくは
２種以上を組み合わせて用いることができる。Specific examples of the active ingredient include indomethacin, L-menthol, bufexamac, zinc oxide, lidocaine, glycyrrhetinic acid, dibucaine hydrochloride,
UV absorbers and the like can be mentioned, and these can be used alone or in combination of two or more.
【００２１】以上のような成分および溶剤が含有されて
なる原液は、後述する噴射剤との関係から、スプレー組
成物全体に対する含有割合が６０〜８０質量％、好まし
くは７５〜８０質量％とされる。特に人体用とされる場
合には、油脂成分がグリセリン脂肪酸エステルよりな
り、石油系溶剤が炭素数１０〜１８の炭化水素系溶剤よ
りなることが好ましい。これにより、５〜３５℃の広い
温度範囲において、容器内にて内容物に流動性が得ら
れ、皮膚への付着率が高くなるという利点が得られる。The stock solution containing the above-mentioned components and solvent has a content of 60 to 80% by mass, preferably 75 to 80% by mass, based on the total amount of the spray composition, in relation to the propellant described later. You. In particular, when used for the human body, it is preferable that the oil component is composed of a glycerin fatty acid ester and the petroleum solvent is composed of a hydrocarbon solvent having 10 to 18 carbon atoms. Thereby, in a wide temperature range of 5 to 35 [deg.] C., there is obtained an advantage that fluidity is obtained in the contents in the container, and the adhesion rate to the skin is increased.
【００２２】本発明のスプレー組成物において、噴射剤
としては、液化石油ガス、ジメチルエーテル、例えば
１，１，１，２−テトラフルオロエタンなどの液化ガス
などが挙げられ、これらは単独で若しくは２種以上を組
み合わせて用いることができる。霧状の吐出物を構成す
る噴霧粒子の飛散を確実に抑制することができることか
ら、噴射剤として液化石油ガスを用いることが好まし
く、特に、その蒸気圧が０．１５〜０．３ＭＰａである
ものが好ましい。In the spray composition of the present invention, examples of the propellant include liquefied petroleum gas and liquefied gas such as dimethyl ether such as 1,1,1,2-tetrafluoroethane. These may be used alone or in combination of two or more. These can be used in combination. It is preferable to use liquefied petroleum gas as a propellant, since the spraying of the spray particles constituting the mist-like discharge can be reliably suppressed, and particularly those having a vapor pressure of 0.15 to 0.3 MPa. Is preferred.
【００２３】噴射剤の含有割合は、スプレー組成物全体
に対して、２０〜４０質量％とされ、好ましくは２５〜
３５質量％とされる。ここで、噴射剤の含有割合が過小
である場合には、良好な噴霧状態が得られず、一方、噴
射剤の含有割合が過大な場合には、容器内に充填するこ
とのできる相対的な原液量が少なくなり、また、適用対
象面への付着率が低くなる。The content of the propellant is 20 to 40% by mass, preferably 25 to 40% by mass, based on the whole spray composition.
35% by mass. Here, when the content ratio of the propellant is too small, a good spray state cannot be obtained. On the other hand, when the content ratio of the propellant is too large, a relative amount that can be filled in the container is not obtained. The amount of undiluted solution decreases, and the rate of adhesion to the surface to be applied decreases.
【００２４】本発明のスプレー組成物は上記のような構
成であって、原液が特定の油脂成分と、当該油脂成分を
溶解する石油系溶剤とを特定の割合で含有してなり、容
器内においては溶解状態にある当該油脂成分が、噴霧吐
出口を介して当該容器から噴霧により吐出されることに
よって析出するようになり、その結果、吐出物を構成す
る噴霧粒子が粘着性を帯びることにより飛散が抑制され
ると共に、当該噴霧粒子の付着性が大きいものとなるこ
とから、適用対象面に対して高い付着率で付着するよう
になる。従って、本発明のスプレー組成物によれば、噴
霧された内容物を高い効率で付着させることができる。The spray composition of the present invention has the above-mentioned constitution, and the stock solution contains a specific fat and oil component and a petroleum-based solvent that dissolves the fat and oil component in a specific ratio. Means that the fat or oil component in a dissolved state is deposited by being sprayed from the container via the spray outlet, and as a result, the spray particles constituting the discharged material are scattered due to becoming sticky. Is suppressed, and the spray particles have high adhesion, so that the spray particles adhere to the application target surface at a high adhesion rate. Therefore, according to the spray composition of the present invention, the sprayed contents can be attached with high efficiency.
【００２５】また、吐出物を構成する噴霧粒子の飛散が
抑制されるため、スプレー組成物を噴霧によって吐出す
る際に使用者などが吸引してむせることを防止すること
ができる。In addition, since the scattering of the spray particles constituting the discharged material is suppressed, it is possible to prevent a user or the like from sucking the spray composition when discharging the spray composition by spraying.
【００２６】本発明のスプレー組成物は、例えば消炎
剤、かゆみ止め剤などの外用薬、スキンケア剤、日焼け
止め剤、トリートメント剤などの化粧品、人体用害虫忌
避剤、ヘアケア剤、その他の人体用として好ましく用い
ることができる。このスプレー組成物を人体用として用
いる場合には、油脂成分の融点が３０〜４０℃であるた
め、吐出することによって析出した油脂成分は、そのま
まで皮膚上において体温によって溶解される。従って、
スプレー組成物の噴霧された内容物を高い効率で均一に
塗布することができる。このように人体用とされる場合
には、油脂成分の融点が３０〜３６℃であることが好ま
しい。これにより、析出した油脂成分を速やかに皮膚上
で確実に溶解させることができるという利点がある。The spray composition of the present invention can be used, for example, for external applications such as anti-inflammatory agents and anti-itch agents, cosmetics such as skin care agents, sunscreen agents and treatment agents, pest repellents for human body, hair care agents and other human body use. It can be preferably used. When this spray composition is used for the human body, since the melting point of the fat and oil component is 30 to 40 ° C., the fat and oil component precipitated by discharging is dissolved as it is on the skin by body temperature. Therefore,
The sprayed contents of the spray composition can be uniformly applied with high efficiency. When used for the human body as described above, the melting point of the fat component is preferably 30 to 36 ° C. Thereby, there is an advantage that the precipitated fat component can be promptly and reliably dissolved on the skin.
【００２７】本発明のスプレー組成物は、人体用に限ら
れず、例えば殺虫剤、住宅用や車用のワックスなどの様
々な用途に用いることができる。[0027] The spray composition of the present invention is not limited to the human body, and can be used for various applications such as insecticides, waxes for houses and cars.
【００２８】[0028]
【実施例】以下、本発明の実施の形態について説明する
が、本発明はこれらにより限定されるものではない。DESCRIPTION OF THE PREFERRED EMBODIMENTS Embodiments of the present invention will be described below, but the present invention is not limited thereto.
【００２９】＜実施例１〜５および比較例１＞表１に示
す処方により原液を調製し、この原液を、表２に示す噴
射剤と共に噴霧吐出口を形成する噴射バルブ装置を備え
た耐圧容器よりなるスプレー容器内に充填することによ
り、スプレー製品を作成した。ここに、比較例１は、油
脂成分を含有しない組成物の例である。<Examples 1 to 5 and Comparative Example 1> A stock solution was prepared according to the formulation shown in Table 1, and the stock solution was provided with an injection valve device for forming a spray outlet with the propellant shown in Table 2. A spray product was prepared by filling into a spray container consisting of: Here, Comparative Example 1 is an example of a composition containing no fat component.
【００３０】以上の実施例１〜５のスプレー製品および
比較例１に係る比較用スプレー製品の各々を、温度を２
５℃に設定した恒温槽内に３０分間保持した後、垂直に
固定した縦２０ｃｍ、横２０ｃｍの平板状の金属板にお
ける面を適用対象面とし、当該金属板から水平方向に１
０ｃｍ離間した位置において、内容物である組成物を３
秒間噴霧させることにより吐出させた。そして、スプレ
ー製品の質量減少量および金属板の質量増加量を測定
し、下記の式（１）により、吐出された原液の量に対す
る適用対象面における付着量の割合である付着率を算出
した。結果を表２に示す。Each of the spray products of Examples 1 to 5 and the comparative spray product of Comparative Example 1 was heated at a temperature of 2
After being kept in a thermostat set at 5 ° C. for 30 minutes, a surface of a vertically fixed metal plate of 20 cm in length and 20 cm in width was set as a target surface to be applied, and 1 mm in a horizontal direction from the metal plate.
At a position separated by 0 cm, 3
It was discharged by spraying for 2 seconds. Then, the amount of mass reduction of the spray product and the amount of mass increase of the metal plate were measured, and the adhesion ratio, which is the ratio of the amount of adhesion on the surface to be applied to the amount of the discharged stock solution, was calculated by the following equation (1). Table 2 shows the results.
【００３１】[0031]
【数１】 (Equation 1)
【００３２】[0032]
【表１】 [Table 1]
【００３３】[0033]
【表２】 [Table 2]
【００３４】表２に示す結果から、実施例１〜５に係る
組成物においては、いずれも９０％以上の高い付着率が
得られており、吐出された原液の殆どが適用対象面に付
着することが確認された。これに対し、比較例１に係る
組成物においては、吐出された原液の半分ほどしか適用
対象面に付着しないことが確認された。From the results shown in Table 2, in the compositions according to Examples 1 to 5, a high adhesion rate of 90% or more was obtained, and almost all of the discharged stock solution adhered to the surface to be applied. It was confirmed that. On the other hand, in the composition according to Comparative Example 1, it was confirmed that only about half of the discharged stock solution adhered to the surface to be applied.
【００３５】以上の結果から、原液が特定の油脂成分
と、当該油脂成分を溶解する石油系溶剤とを特定の割合
で含有してなるスプレー組成物は、噴霧された内容物が
高い効率で付着されることが確認された。From the above results, it can be seen that the spray composition in which the stock solution contains the specific fat and oil component and the petroleum solvent that dissolves the fat and oil component in the specific ratio has the sprayed content adhered with high efficiency. It was confirmed that it would be.
【００３６】[0036]
【発明の効果】本発明のスプレー組成物によれば、原液
が、特定の油脂成分と当該油脂成分を溶解させる石油系
溶剤とを特定の割合で含有してなり、噴霧により霧状に
吐出される吐出物を構成する噴霧粒子において油脂成分
が析出するため、当該噴霧粒子が粘着性を帯びることに
より大径の粒子となり、飛散が抑制されると共に、当該
噴霧粒子の付着性が大きいものとなることから、適用対
象面に対して高い付着率で付着するようになり、従っ
て、噴霧された内容物が高い効率で付着される。According to the spray composition of the present invention, the stock solution contains a specific fat and oil component and a petroleum-based solvent that dissolves the fat and oil component in a specific ratio, and is discharged in the form of a mist by spraying. The oil and fat component precipitates in the spray particles constituting the discharged material, so that the spray particles take on tackiness and become large-diameter particles, thereby suppressing scattering and increasing the adhesion of the spray particles. As a result, the adhered material adheres to the surface to be applied at a high adhesion rate, and therefore, the sprayed contents are adhered with high efficiency.
Claims (4)
４０質量％とよりなり、 原液が、融点が３０〜４０℃である油脂成分６０〜９０
質量％と、当該油脂成分を溶解する石油系溶剤１０〜４
０質量％とを含有することを特徴とするスプレー組成
物。1. An undiluted solution of 60 to 80% by mass and a propellant of 20 to 80%
40 mass%, and the undiluted solution has a melting point of 30 to 40 ° C.
% By mass and a petroleum-based solvent that dissolves the fat component.
0% by mass of the spray composition.
当該噴霧吐出口を介して吐出された吐出物において、原
液中の油脂成分が析出することを特徴とする請求項１に
記載のスプレー組成物。2. Filled in a container having a spray outlet,
2. The spray composition according to claim 1, wherein a fat component in the undiluted solution precipitates in the discharged material discharged through the spray discharge port. 3.
によって析出した油脂成分が、皮膚上において溶解する
ことを特徴とする請求項２に記載のスプレー組成物。3. The spray composition according to claim 2, which is used for a human body and dissolves an oil component precipitated by being discharged on the skin.
りなり、 石油系溶剤が炭素数１０〜１８の炭化水素系溶剤である
ことを特徴とする請求項１〜請求項３のいずれかに記載
のスプレー組成物。4. The spray composition according to claim 1, wherein the oil component comprises a glycerin fatty acid ester, and the petroleum solvent is a hydrocarbon solvent having 10 to 18 carbon atoms. object.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000328836A JP2002138015A (en) | 2000-10-27 | 2000-10-27 | Spray composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000328836A JP2002138015A (en) | 2000-10-27 | 2000-10-27 | Spray composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002138015A true JP2002138015A (en) | 2002-05-14 |
Family
ID=18805628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000328836A Pending JP2002138015A (en) | 2000-10-27 | 2000-10-27 | Spray composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002138015A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008031170A (en) * | 2006-07-25 | 2008-02-14 | L'oreal Sa | Oily cosmetic composition in aerosol form |
| JP2010235576A (en) * | 2009-03-10 | 2010-10-21 | Toyo Aerosol Ind Co Ltd | Fusible oil-and-fat aerosol composition for human body |
| US10130640B2 (en) | 2010-06-11 | 2018-11-20 | Leo Pharma A/S | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
-
2000
- 2000-10-27 JP JP2000328836A patent/JP2002138015A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008031170A (en) * | 2006-07-25 | 2008-02-14 | L'oreal Sa | Oily cosmetic composition in aerosol form |
| JP2010235576A (en) * | 2009-03-10 | 2010-10-21 | Toyo Aerosol Ind Co Ltd | Fusible oil-and-fat aerosol composition for human body |
| US10130640B2 (en) | 2010-06-11 | 2018-11-20 | Leo Pharma A/S | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
| US10617698B2 (en) | 2010-06-11 | 2020-04-14 | Leo Pharma A/S | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid |
| US10660908B2 (en) | 2010-06-11 | 2020-05-26 | Leo Pharma A/S | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
| US10682364B2 (en) | 2010-06-11 | 2020-06-16 | Leo Pharma A/S | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid |
| US10688108B2 (en) | 2010-06-11 | 2020-06-23 | Leo Pharma A/S | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
| US10716799B2 (en) | 2010-06-11 | 2020-07-21 | Leo Pharma A/S | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU628115B2 (en) | Self-foaming oil compositions and process for making and using same | |
| US4001391A (en) | Means for depositing aerosol sprays in buttery form | |
| US9737481B2 (en) | Spray foam corticosteroid product | |
| AU766944B2 (en) | Aerosol ointment compositions and method of manufacture | |
| JP2004536116A5 (en) | ||
| JP2005507013A (en) | Changing the viscosity of petroleum distillates | |
| US5223251A (en) | Skin fragrance compositions | |
| CN1723007B (en) | Aerosol Delivery System | |
| FR2695133A1 (en) | Fluid compositions, rapidly foaming, soap-free, containing a lower hydrocarbon, and propelled into a pressurized container of compressed gas. | |
| JP6388401B2 (en) | Non aerosol spray products | |
| JP2008189644A (en) | Self-foamable skin-cleaning agent composition | |
| US4035267A (en) | Dry shampoo using chitin powder | |
| JP2026010093A (en) | Personal care aerosol compositions, methods and devices | |
| JPH07233091A (en) | Device for dispensing therapeutic or cosmetic substances and compositions intended for use in a device using a volatile polydiorganosiloxane as an inert excipient | |
| JP2002138015A (en) | Spray composition | |
| JP7429504B2 (en) | Injection device, composition injection method, and composition for injection | |
| US10085926B2 (en) | Nail polish remover compositions and methods | |
| EP3481439B1 (en) | Air freshening formulation, aerosol product and method of freshening the air | |
| JP3755903B2 (en) | Gel spray composition | |
| JP2795351B2 (en) | Aerosol composition for human body | |
| DE69821010T2 (en) | AEROSOL SALBEN-PREPARATIONS | |
| JP6847538B2 (en) | Aerosol type gel deodorant | |
| JPH11209267A (en) | Aerosol composition for antiinflammatory gel | |
| JPS5964688A (en) | Aerosol composition | |
| WO1999007344A1 (en) | Powdery aerosol preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070115 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20081106 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081118 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090116 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090210 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090623 |